Appeal No. 2001-2271 Page 6 Application No. 08/971,839 stand or fall with claim 1. Accordingly, the rejection of claims 1, 2, 7, 10 and 11 is affirmed. The Rejection of Claims 1, 2, 7, 10 and 11 Claim 3 specifies that the biological agent is calcein or oxytetracycline hydrochloride, neither of which is disclosed by Zohar or Heat Systems Ultrasonics. Thus, the examiner relies on Monaghan and Mohler as evidence that both were well known in the art as chemical markers “especially when mass-marketing larval fish for long-term hatchery product evaluation” (Answer, page 8). Appellants argue that the Monaghan and Mohler references “are not relevant to the claimed distinction involved herein,” i.e., maintaining a constant temperature during ultrasonification, “even though they are relevant to other limitations of the second group of claims” (Brief, page 5). Inasmuch as we have found no error in the examiner’s determination that Zohar and Heat Systems Ultrasonics are sufficient to establish that “it would have been prima facie obvious . . . to maintain the temperature constant at a temperature . . . during [ ] ultrasonic . . . infus[ion of] compounds into aquatic organisms,” and appellants agree that Monaghan and Mohler “are relevant to other limitations of the second group of claims,” we affirm the examiner’s rejection of claims 3-5, 8 and 13 as well.Page: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007